Ofatumumab
Showing 151 - 163 of 163
Leukaemia, Lymphocytic, Chronic Trial (ofatumumab)
Completed
- Leukaemia, Lymphocytic, Chronic
- ofatumumab
- (no location specified)
May 29, 2014
Chronic Lymphocytic Leukemia Trial in Iowa City (HuMax-CD20)
Withdrawn
- Chronic Lymphocytic Leukemia
-
Iowa City, IowaUniversity of Iowa, Hospitals and Clinics
Apr 20, 2015
Lymphoma, Follicular Trial in Iowa City (HuMax-CD20)
Withdrawn
- Lymphoma, Follicular
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Apr 20, 2015
Leukaemia, Lymphocytic, Chronic Trial in Houston, Plymouth (Ofatumumab 500mg, Ofatumumab 1000mg, Fludarabine)
Completed
- Leukaemia, Lymphocytic, Chronic
- Ofatumumab 500mg
- +3 more
-
Houston, Texas
- +1 more
Dec 19, 2013
Lymphoma, Follicular Trial in Southampton (Ofatumumab)
Completed
- Lymphoma, Follicular
- Ofatumumab
-
Southampton, United KingdomGSK Investigational Site
Dec 12, 2013
Arthritis, Rheumatoid Trial in Worldwide (Ofatumumab, Placebo)
Terminated
- Arthritis, Rheumatoid
- Ofatumumab
- Placebo
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
- +59 more
May 22, 2014
Leukaemia, Lymphoblastic Trial in Japan (chlorambucil, tablets)
Completed
- Leukaemia, Lymphoblastic
- chlorambucil, tablets
-
Aichi, Japan
- +5 more
Jun 4, 2015
Lymphoma, Large-Cell, Diffuse Trial (ofatumumab + ICE, ofatumumab + DHAP)
Completed
- Lymphoma, Large-Cell, Diffuse
- ofatumumab + ICE
- ofatumumab + DHAP
- (no location specified)
Mar 7, 2013
Chronic Lymphocytic Leukaemia Trial in United Kingdom (Ofatumumab, Chlorambucil, Bendamustine)
Unknown status
- Chronic Lymphocytic Leukaemia
- Ofatumumab
- +2 more
-
Chester, Cheshire, United Kingdom
- +27 more
Oct 12, 2012
Non-Hodgkin's Lymphoma (NHL) Trial in Belgium, Israel, United States (Bendamustine HCl, Ofatumumab)
Completed
- Non-Hodgkin's Lymphoma (NHL)
- Bendamustine hydrochloride
- Ofatumumab
-
Birmingham, Alabama
- +38 more
Jul 24, 2012
Bendamustine With or Without Rituximab in Chronic
Completed
- Chronic Lymphocytic Leukaemia
-
Cosenza, CZ, Italy
- +2 more
Apr 12, 2013
Lymphoma, Mantle-Cell Trial in Milano, Reggio Di Calabria (Combination of dexamethasone, ofatumumab and bendamustine)
Unknown status
- Lymphoma, Mantle-Cell
- Combination of dexamethasone, ofatumumab and bendamustine
-
Milano, Italy
- +1 more
Sep 12, 2011